Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0000899243-21-014672

Director acquired 12,151 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Prelack Steven Director 2021-03-31 Grant or award +12,151 $1.54 $18,749 12,151 D: show line 1 in the form
Loading xslF345X03/doc4.xml…